160 related articles for article (PubMed ID: 7522717)
21. Trisomy 4 in a case of acute lymphocytic leukemia (L1).
Hodohara K; Fujiyama Y; Inoue T; Niwakawa M; Kitoh K; Andoh A; Bamba T; Hosoda S; Abe T
Cancer Genet Cytogenet; 1992 Aug; 62(1):88-91. PubMed ID: 1521241
[TBL] [Abstract][Full Text] [Related]
22. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
23. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
24. Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers.
Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Bosly A; Doyen C; Carli MG; Piva N; Castoldi G
Leuk Lymphoma; 1993 Mar; 9(4-5):285-91. PubMed ID: 8348065
[TBL] [Abstract][Full Text] [Related]
25. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO).
Iwata H; Kami M; Kishi Y; Oki Y; Tanaka Y; Takeuchi K; Yamazaki I; Suzuki R; Morinaga S; Mutou Y
Leukemia; 2000 Nov; 14(11):2013-4. PubMed ID: 11069040
[No Abstract] [Full Text] [Related]
26. Trisomy 10 as the sole abnormality in biphenotypic leukemia.
Inoue T; Fujiyama Y; Kitamura S; Andoh A; Hodohara K; Bamba T
Leuk Lymphoma; 2000 Oct; 39(3-4):405-9. PubMed ID: 11342322
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukemia with concomitant trisomies 4 and 10: a distinctive form of myeloid leukemia?
Wong KF; So CC
Cancer Genet Cytogenet; 2001 May; 127(1):74-6. PubMed ID: 11408070
[TBL] [Abstract][Full Text] [Related]
28. Isolated tetrasomy 8 in minimally differentiated acute myeloid leukemia (AML-M0).
Xue Y; Guo Y; Zhou Y; Xie X; Zheng L; Shen M
Leuk Lymphoma; 1999 May; 33(5-6):581-5. PubMed ID: 10342586
[TBL] [Abstract][Full Text] [Related]
29. Cellular characteristics of acute myeloblastic leukemia associated with t(8;21)(q22;q22). The Japanese Cooperative Group of Leukemia/Lymphoma.
Kita K; Shirakawa S; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):229-34. PubMed ID: 8049646
[TBL] [Abstract][Full Text] [Related]
30. Immunological and ultrastructural studies in acute biphenotypic leukaemia.
Shetty V; Chitale A; Matutes E; Buccheri V; Morilla R; Catovsky D
J Clin Pathol; 1993 Oct; 46(10):903-7. PubMed ID: 8227405
[TBL] [Abstract][Full Text] [Related]
31. Acute leukemia with natural killer cells antigens in Brazilian children.
Pombo-de-Oliveira MS; Campos MM; Bossa YE; Alencar DM; Curvello C; Agudelo DP; Mendonça N; Pereira E; Macedo-Silva ML
Leuk Lymphoma; 2004 Apr; 45(4):739-43. PubMed ID: 15160949
[TBL] [Abstract][Full Text] [Related]
32. Trisomy 13 and myeloid malignancy--characteristic blast cell morphology: a United Kingdom Cancer Cytogenetics Group survey.
Mehta AB; Bain BJ; Fitchett M; Shah S; Secker-Walker LM
Br J Haematol; 1998 Jun; 101(4):749-52. PubMed ID: 9674750
[TBL] [Abstract][Full Text] [Related]
33. [Immunophenotypic and immunogenotypic analyses of acute leukemia and lymphoblastic lymphoma expressing myeloid and lymphoid antigens].
Kawamura K; Tobinai K
Rinsho Byori; 1992 Jul; 40(7):761-8. PubMed ID: 1507495
[TBL] [Abstract][Full Text] [Related]
34. Acute undifferentiated leukemia with CD7+ and CD13+ immunophenotype. Lack of molecular lineage commitment and association with poor prognostic features.
Bassan R; Biondi A; Benvestito S; Tini ML; Abbate M; Viero P; Barbui T; Rambaldi A
Cancer; 1992 Jan; 69(2):396-404. PubMed ID: 1370211
[TBL] [Abstract][Full Text] [Related]
35. Immunologic classification of acute lymphoblastic leukemia.
Cabrera ME
Am J Pediatr Hematol Oncol; 1990; 12(3):283-91. PubMed ID: 2240474
[TBL] [Abstract][Full Text] [Related]
36. MYC amplification in two further cases of acute myeloid leukemia with trisomy 4 and double minute chromosomes.
O'Malley F; Rayeroux K; Cole-Sinclair M; Tong M; Campbell LJ
Cancer Genet Cytogenet; 1999 Mar; 109(2):123-5. PubMed ID: 10087944
[TBL] [Abstract][Full Text] [Related]
37. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
38. Terminal transferase expression in the differential diagnosis of acute leukemias. Eastern Cooperative Oncology Group.
Meenan B; Heavey C; Lichtenstein A; Andersen J; Paietta E
Leuk Lymphoma; 1996 Jul; 22(3-4):265-9. PubMed ID: 8819075
[TBL] [Abstract][Full Text] [Related]
39. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
40. Chromosome 21 rearrangement in acute biphenotypic leukemia.
Theodossiou C; Scalise A; Silverman L; Najfeld V
Cancer Genet Cytogenet; 1992 Nov; 64(1):56-9. PubMed ID: 1360869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
